Hormone transport via blood allows endocrine signals released by ductless glands to reach target tissues throughout the body. Hormones may circulate freely or bound to plasma proteins, with their chemical properties determining solubility, carrier requirements, distribution, half-life, and availability to target cells.
Hormone transport via blood is the principal mechanism by which endocrine glands communicate with anatomically distant target tissues. Endocrine cells release hormones into the surrounding interstitial fluid, and these chemical messengers subsequently enter nearby capillaries. Once within the circulation, hormones are distributed throughout the body by the cardiovascular system.
Hormones differ considerably in the way they travel through blood. Water-soluble hormones, including most peptide hormones and catecholamines, generally circulate predominantly in dissolved form. Lipid-soluble hormones, particularly steroid and thyroid hormones, circulate largely bound to plasma carrier proteins.
The method of transport influences several important properties of a hormone, including its distribution, biological availability, rate of clearance, circulating half-life, and the relationship between its total and free concentrations.
Endocrine glands lack excretory ducts. Their secretory products therefore enter the extracellular compartment surrounding endocrine cells rather than being delivered into a duct.
Hormones move from the interstitial fluid into nearby blood vessels, allowing the circulation to function as the principal long-distance transport system of endocrine signaling.
| Step | Process |
|---|---|
| 1 | Endocrine cell synthesizes or releases a hormone |
| 2 | Hormone enters surrounding interstitial fluid |
| 3 | Hormone enters nearby capillaries |
| 4 | Blood carries the hormone through the circulation |
| 5 | Hormone reaches the microcirculation of target tissues |
| 6 | Hormone leaves the vascular compartment or interacts with accessible target cells |
| 7 | Hormone binds to its specific receptor and produces a cellular response |
The cardiovascular system connects endocrine tissues with target organs located throughout the body. A hormone secreted by one anatomically localized gland can therefore influence tissues located far from its site of production.
For example, TSH released from the anterior pituitary travels through the systemic circulation to the thyroid gland, while thyroid hormones released from the thyroid can subsequently reach tissues throughout the body.
Many endocrine glands are highly vascular. Their endocrine cells are positioned close to extensive capillary networks, allowing hormones to enter the circulation efficiently.
This vascular organization is particularly important because endocrine glands do not possess ducts for transporting their secretions.
Many endocrine tissues contain fenestrated capillaries. Fenestrations within the endothelial cells facilitate exchange between blood and the surrounding endocrine tissue.
Examples of endocrine organs with specialized permeable microvasculature include the anterior pituitary, thyroid gland, parathyroid glands, adrenal glands, and pancreatic islets.
Hormones are physiologically effective at relatively low circulating concentrations. Their concentrations reflect the balance among secretion, distribution, binding, metabolism, and elimination.
A change in circulating hormone concentration can therefore result from altered secretion or from changes in any of the processes controlling hormone transport and clearance.
The chemical structure of a hormone strongly influences its behavior in blood. Hormones can be broadly divided into water-soluble and lipid-soluble groups for purposes of understanding transport.
| Hormone Type | Typical Blood Transport |
|---|---|
| Peptide and protein hormones | Predominantly free in plasma |
| Catecholamines | Predominantly free in plasma |
| Steroid hormones | Largely protein-bound |
| Thyroid hormones | Strongly protein-bound |
Water-soluble hormones can dissolve readily in the aqueous environment of plasma. Most peptide hormones, protein hormones, glycoprotein hormones, and catecholamines belong to this functional category.
These hormones generally do not require specific carrier proteins for most of their transport through blood.
Hormones such as insulin, glucagon, growth hormone, ACTH, parathyroid hormone, and many hypothalamic and pituitary hormones are peptides or proteins.
They generally circulate in a predominantly unbound form and can be delivered directly through plasma to their target tissues.
Several anterior pituitary hormones, including TSH, LH, and FSH, are glycoproteins. Like other water-soluble hormones, they circulate through the aqueous plasma compartment without requiring extensive binding to transport proteins.
The catecholamines epinephrine and norepinephrine are derived from tyrosine but remain relatively water soluble.
When released from the adrenal medulla, they circulate predominantly in free form and generally have relatively short circulating half-lives.
Lipid-soluble hormones have limited solubility in the aqueous environment of plasma. They therefore commonly associate with plasma proteins during circulation.
The principal endocrine examples are steroid hormones and thyroid hormones.
Steroid hormones are derived from cholesterol and include cortisol, aldosterone, testosterone, estradiol, and progesterone.
Most circulating steroid hormone molecules are reversibly bound to plasma proteins, while a smaller fraction remains unbound.
The thyroid hormones thyroxine (T4) and triiodothyronine (T3) are poorly soluble in water and circulate predominantly bound to plasma proteins.
Only a small proportion of circulating thyroid hormone remains free at any particular time.
For hormones that bind plasma proteins, the circulating hormone pool can be divided into free hormone and protein-bound hormone.
These fractions exist in reversible equilibrium with one another.
The free fraction consists of hormone molecules not bound to plasma carrier proteins.
For many protein-bound hormones, the free fraction is the component most immediately available to enter tissues, bind receptors, undergo metabolism, or be cleared from the circulation.
The bound fraction consists of hormone molecules reversibly associated with plasma proteins.
Binding limits immediate diffusion and clearance while creating a circulating reservoir from which additional free hormone can become available.
Free and bound hormone molecules continuously exchange. When free hormone leaves the circulation or is metabolized, some protein-bound hormone can dissociate from carrier proteins and replenish the free fraction.
This dynamic equilibrium helps stabilize the concentration of biologically available hormone.
Hormone-binding proteins can be relatively specific for particular hormones or can bind a broader range of hydrophobic molecules.
Important endocrine carrier proteins include:
Thyroxine-binding globulin is an important high-affinity carrier protein for thyroid hormones.
T4 and T3 also bind to other plasma proteins, particularly transthyretin and albumin.
Transthyretin contributes to transport of thyroid hormones, particularly T4.
It is one of several proteins participating in the circulating thyroid hormone-binding system.
Corticosteroid-binding globulin (CBG), also called transcortin, binds glucocorticoids, particularly cortisol, in the circulation.
A proportion of circulating cortisol also binds to albumin, while a smaller fraction remains free.
Sex hormone-binding globulin (SHBG) binds several sex steroids, particularly testosterone and estradiol.
Changes in SHBG concentration can alter the relationship between total and free concentrations of these hormones.
Albumin is an abundant plasma protein capable of binding numerous hormones and other hydrophobic molecules.
Its binding affinity for many hormones is lower than that of specialized carrier globulins, but its high plasma concentration makes it an important component of hormone transport.
Binding proteins perform several important functions in hormone transport:
Protein-bound hormone acts as a circulating reservoir. As free hormone is removed from plasma, additional hormone can dissociate from carrier proteins.
This mechanism can help maintain free hormone availability despite ongoing uptake, metabolism, and elimination.
Binding to plasma proteins can protect hormones from rapid clearance. A hormone associated with a large carrier protein is less readily filtered by the renal glomeruli than the same hormone circulating freely.
Protein binding can also reduce immediate access to metabolic enzymes.
The half-life of a hormone is the time required for its circulating concentration to decrease by approximately one-half under defined conditions.
Hormone half-life depends on multiple factors, including protein binding, metabolism, tissue uptake, renal elimination, hepatic clearance, and continued secretion.
Hormones that circulate extensively bound to proteins often have longer circulating half-lives than rapidly cleared water-soluble hormones.
For example, thyroid hormones are strongly protein-bound and remain in the circulation much longer than catecholamines.
| Feature | Water-Soluble Hormones | Lipid-Soluble Hormones |
|---|---|---|
| Plasma solubility | Relatively high | Relatively low |
| Carrier proteins | Usually not required extensively | Commonly important |
| Free circulating fraction | Usually relatively large | Often relatively small |
| Typical half-life | Often shorter | Often longer |
| Examples | Insulin, ACTH, epinephrine | Cortisol, testosterone, T4 |
Blood flow carries endocrine hormones throughout the body, but hormone delivery to an individual tissue depends partly on the tissue's vascular perfusion.
Highly perfused tissues are exposed rapidly to circulating hormones, whereas delivery to less perfused tissues may occur more slowly.
Perfusion refers to the delivery of blood to a tissue. Changes in cardiac output, regional vascular resistance, or local blood flow can therefore influence the rate at which hormones reach target tissues.
Transport through blood is consequently linked to cardiovascular physiology.
After reaching a target tissue, hormones must gain access to the appropriate cellular compartment. Depending on hormone size, chemical properties, and capillary structure, this can involve movement through endothelial junctions, fenestrations, or other exchange pathways.
Blood distributes hormones widely, but distribution alone does not determine biological response. A cell must possess an appropriate hormone receptor and the necessary intracellular signaling machinery to respond.
Thus, a hormone may pass through the circulation of many organs while producing substantial effects only in selected target cells.
Most water-soluble hormones cannot freely cross the lipid bilayer of the plasma membrane. They therefore commonly bind to receptors located on the cell surface.
These receptors activate intracellular signaling pathways that translate the extracellular hormonal signal into a cellular response.
Steroid hormones and thyroid hormones act predominantly through intracellular receptors.
After reaching target tissues and becoming available to cells, these hormones interact with receptors located in the cytoplasm or nucleus, depending on the hormone and receptor type.
Total hormone concentration represents the combined amount of free and protein-bound hormone measured in blood.
For strongly protein-bound hormones, most of the measured total concentration may represent hormone associated with carrier proteins.
Free hormone concentration represents the circulating hormone not bound to plasma proteins.
Measurement of free hormone can be particularly useful when changes in carrier proteins make total hormone concentrations difficult to interpret.
An increase or decrease in a hormone-binding protein can alter total circulating hormone concentration even when the physiologically regulated free hormone concentration remains relatively stable.
This distinction is important when interpreting laboratory measurements of thyroid and steroid hormones.
If the concentration of a binding protein increases, more hormone can become protein-bound. Initially, the free concentration may fall, which can alter endocrine feedback and stimulate compensatory hormone secretion.
After a new equilibrium is established, total hormone may be increased while free hormone returns toward its regulated physiological range.
Pregnancy can alter concentrations of several plasma binding proteins. Increased estrogen exposure can increase proteins such as thyroxine-binding globulin and corticosteroid-binding globulin.
Consequently, total thyroid hormone and cortisol concentrations can differ from values expected outside pregnancy without representing equivalent increases in their free fractions.
The traditional free hormone hypothesis proposes that the unbound fraction of many protein-bound hormones is the fraction most readily available to enter cells and exert biological effects.
Hormone transport biology is more complex in some tissues because carrier proteins and cellular uptake mechanisms can also influence hormone delivery.
Binding between hormones and plasma proteins is generally reversible. Hormone molecules continuously associate with and dissociate from their carriers.
Only molecules that dissociate from the carrier are immediately available for many forms of tissue uptake, receptor interaction, metabolism, and elimination.
Hormone clearance refers to removal of hormone from the circulation through metabolism, excretion, cellular uptake, or other processes.
The liver and kidneys are particularly important in the metabolism and elimination of many endocrine hormones.
The liver metabolizes many hormones through enzymatic modification and conjugation. These processes can reduce biological activity and increase water solubility, facilitating elimination.
Altered hepatic function can therefore influence circulating concentrations of some hormones.
The kidneys contribute to elimination or metabolism of numerous hormones and their metabolites.
Small free molecules may undergo glomerular filtration, while protein-bound hormone is generally less readily filtered.
Hormonal metabolism can produce inactive metabolites, less active compounds, or in some cases biologically active products.
Circulating measurements may therefore distinguish between a parent hormone and its metabolites depending on the physiological or clinical question.
Some endocrine products circulate as precursors that are converted into more active molecules in peripheral tissues.
For example, much of the T4 released by the thyroid functions as a circulating precursor for production of the more biologically active thyroid hormone T3.
Hormone transport through blood allows precursor hormones to reach tissues containing enzymes capable of modifying them.
This creates an additional level of endocrine regulation because local tissues can influence the amount of active hormone available within their own cellular environment.
Thyroid hormone transport illustrates several major principles simultaneously. T4 and T3 circulate predominantly bound to plasma proteins, particularly TBG, transthyretin, and albumin.
A small free fraction remains available for tissue uptake, while peripheral deiodinases can convert T4 into active T3 or inactive metabolites.
Cortisol circulates partly bound to corticosteroid-binding globulin and albumin, with a smaller free fraction.
Protein binding contributes to the circulating cortisol reservoir and affects the relationship between total and biologically available hormone.
Testosterone and estradiol circulate partly associated with SHBG and albumin.
Changes in SHBG can therefore alter measured total sex steroid concentrations and the proportion of hormone available in unbound or loosely bound forms.
Insulin is a peptide hormone and circulates primarily without a dedicated transport protein. After secretion from pancreatic beta cells, it enters the pancreatic microcirculation and subsequently reaches the liver through the portal circulation before entering the systemic circulation.
This anatomical arrangement exposes the liver to relatively high concentrations of newly secreted insulin.
Not all endocrine hormones enter the general systemic circulation immediately. Some first travel through specialized portal circulations.
Portal systems allow a hormone released from one tissue to reach another regulatory tissue at relatively high concentrations before becoming diluted in the systemic circulation.
The hypothalamic-hypophyseal portal system transports hypothalamic releasing and inhibiting hormones from the median eminence directly to the anterior pituitary.
This arrangement permits small quantities of hypothalamic hormones to regulate pituitary endocrine cells efficiently.
Hormones secreted from pancreatic islets enter venous blood that ultimately drains through the hepatic portal system.
The liver is therefore exposed to pancreatic endocrine hormones before the blood reaches the general systemic circulation.
Blood transport is essential for many endocrine feedback loops. Peripheral hormones must reach upstream regulatory structures such as the hypothalamus and pituitary to provide feedback information.
Similarly, pituitary trophic hormones must reach peripheral endocrine glands through the circulation.
In the hypothalamic-pituitary-thyroid axis, TRH travels through the hypophyseal portal circulation to the anterior pituitary. TSH then travels through systemic blood to the thyroid gland.
Thyroid hormones subsequently circulate back to the pituitary and hypothalamic regulatory systems while also reaching peripheral tissues throughout the body.
In the hypothalamic-pituitary-adrenal axis, CRH reaches the anterior pituitary through portal blood, ACTH reaches the adrenal cortex through systemic circulation, and cortisol returns through the circulation to exert effects on target tissues and feedback regulatory centers.
The speed of an endocrine response depends on more than blood transport alone. Hormone synthesis, secretion, circulation, receptor interaction, intracellular signaling, and gene regulation all contribute to the overall response time.
Water-soluble hormones acting through membrane receptors can often produce relatively rapid cellular responses, while hormones acting through transcriptional mechanisms may have slower but longer-lasting effects.
A circulating hormone can be distributed widely throughout the body. Specificity is produced primarily by receptor expression and cellular responsiveness rather than by delivery of the hormone exclusively to one organ.
This allows one circulating hormone to affect several tissues differently depending on the receptors and signaling pathways present in each cell type.
| Feature | Endocrine Signaling | Paracrine Signaling |
|---|---|---|
| Major transport route | Blood circulation | Local extracellular fluid |
| Typical distance | Can be long distance | Usually nearby cells |
| Systemic distribution | Common | Usually limited |
| Target specificity | Determined by receptors | Determined by local exposure and receptors |
Conventional neurons typically release neurotransmitters into a synaptic cleft, where the signaling molecule travels only a very short distance.
Neuroendocrine cells differ because they release signaling molecules into blood, allowing neural activity to generate systemic hormonal effects.
Because endocrine hormones travel through blood, many aspects of endocrine function can be evaluated by measuring hormone concentrations in serum or plasma.
Interpretation requires consideration of secretion patterns, binding proteins, time of sampling, physiological state, medications, and the relationship between regulatory and target-gland hormones.
Some hormones are released in pulses. A single blood sample may therefore capture a peak, trough, or intermediate concentration rather than representing average secretion over a longer period.
Examples of hormones with important pulsatile patterns include growth hormone, GnRH-related gonadotropins, and ACTH.
Several endocrine hormones vary according to circadian rhythms. Cortisol provides a prominent example, with circulating concentrations changing predictably across the day under normal physiological conditions.
The timing of blood collection can therefore be important when interpreting certain endocrine tests.
Changes in hormone-binding proteins can alter total circulating hormone concentrations without producing corresponding changes in endocrine activity.
Recognizing this principle can prevent abnormalities in total hormone measurements from being mistaken automatically for excessive or deficient hormone action.
| Hormone Class | Examples | Typical Transport Pattern | General Circulating Behavior |
|---|---|---|---|
| Peptide/protein | Insulin, GH, ACTH, PTH | Mostly free | Often relatively short half-life |
| Glycoprotein | TSH, LH, FSH | Mostly free | Water soluble |
| Catecholamine | Epinephrine, norepinephrine | Predominantly free | Rapidly cleared |
| Steroid | Cortisol, aldosterone, testosterone, estradiol | Variable but often substantially protein-bound | Binding can prolong circulating availability |
| Thyroid hormone | T4, T3 | Strongly protein-bound | Relatively long circulating persistence |
| Carrier Protein | Important Hormones Transported |
|---|---|
| Thyroxine-binding globulin | T4 and T3 |
| Transthyretin | Primarily T4 |
| Corticosteroid-binding globulin | Primarily cortisol |
| Sex hormone-binding globulin | Testosterone, estradiol, and related sex steroids |
| Albumin | Multiple steroid and thyroid hormones with relatively lower affinity |
| Feature | Key Point |
|---|---|
| Primary transport system | Cardiovascular circulation |
| Entry into blood | Hormones pass from endocrine tissue through interstitial fluid into capillaries |
| Water-soluble hormones | Generally circulate predominantly free |
| Lipid-soluble hormones | Frequently circulate bound to plasma proteins |
| Free hormone | Immediately available for many forms of tissue uptake and clearance |
| Bound hormone | Provides transport and a circulating reservoir |
| Protein binding | Can prolong hormone half-life and reduce rapid clearance |
| Target specificity | Determined primarily by receptor expression |
| Clearance | Commonly involves liver, kidneys, tissue uptake, and metabolism |
| Clinical assessment | Hormones can often be measured in serum or plasma |
Hormone transport through blood provides the anatomical connection between endocrine glands and distant target organs. Endocrine tissues can therefore regulate structures located far from their sites of secretion without requiring a physical duct or direct neural connection to every target cell.
The microvascular anatomy of endocrine glands is adapted to this function. Endocrine cells commonly lie close to extensive capillary networks, allowing secreted hormones to enter blood rapidly. Specialized portal systems provide even more direct communication in certain pathways, particularly between the hypothalamus and anterior pituitary and between the gastrointestinal-pancreatic circulation and liver.
The chemical properties of each hormone determine how it behaves once it enters blood. Water-soluble peptide hormones and catecholamines generally circulate largely in free form, while hydrophobic steroid and thyroid hormones depend substantially on plasma carrier proteins. Protein binding increases effective transport capacity, creates a circulating reservoir, reduces rapid clearance, and influences hormone half-life.
Transport through blood does not itself determine which tissues respond to a hormone. The circulation exposes many tissues to the same endocrine signal, while receptor expression and intracellular signaling determine biological specificity. A single circulating hormone can consequently produce different effects in different organs.
Blood transport also makes endocrine feedback possible. Peripheral hormones can return to the hypothalamus and pituitary, pituitary hormones can reach peripheral endocrine glands, and metabolic hormones can respond to circulating physiological variables. The cardiovascular system therefore serves not merely as a passive carrier of hormones but as the distribution network that allows anatomically separated endocrine tissues to function as an integrated regulatory system.